Market Overview
Market
Research Future (MRFR) has published a report about the global influenza
diagnostics market share expects 5.3% CAGR during the forecast period between
2023-2032. In terms of cash, this market is expected to grow with USD 1.81
billion by 2032. This report analyzes the market, potential for growth during
the forecast period, market sizes around the world, key players in the market,
product launches and latest research and development (R&D).
Influenza
as an illness can cause severe complications and mess up anybody's medical
history. Influenza is of various types and with a variety of deadly symptoms.
Hence, early diagnosis of influenza can reduce the chances of further
complications. Therefore, with World Health Organization (WHO) confirming about
600 million Influenza cases worldwide, the services offering accurate Influenza
diagnosis are going to be in-demand always and become a part of a huge market
in the medical sector.
Key Players
Global
influenza diagnostics market players include
Alere
(USA),
BD
(USA),
Becton
Dickinson (USA),
BioMérieux
SA (France),
Cepheid
(USA),
Hardy
Diagnostics(USA),
LifeSign
LLC.(USA),
Meridian
Bioscience, Inc.(USA),
Quidel
Corporation (USA),
Roche
Molecular Systems Inc.(Switzerland), and
Sekisui
Diagnostics (USA).
Market Segmentation
The
global influenza diagnostics
market overview is segmented on the basis of types, tests, and region. The
segmentation of types comprises of type A flu, type B flu, type C flu. The
three forms of type A are bird flu, seasonal flu, and Swine flu. Bird Flu is
known as Avian Influenza which is caused by viruses adapted to birds. It can be
caused by eating infected birds. Seasonal flu is common cold whose viruses
become active only during the change of seasons as human body becomes adapt to
the new season slowly. Similar to bird flu, swine flu is an infection caused by
any one of several types of swine influenza viruses. Swine influenza virus
(SIV) or swine-origin influenza virus (S-OIV) are the viruses causing this
infection. These viruses are found in pigs. Type B flu is found only in humans.
Influenza type B viruses are not classified by subtype and do not cause
pandemics. It is caused by a genus called Influenzavirus B which is from the
virus family Orthomyxoviridae. Type C Influenza viruses are from
Orthomyxoviridae family. They are not as severe as Type A or B but can cause
local epidemics.
On
the basis of tests, the market has been segmented into direct fluorescent
antibody (DFA) tests, molecular tests, nucleic acid sequence-based
amplification (NASBA) tests, rapid influenza detection tests (RIDT),
serological assays, simple amplification-based assays (SAMBA) and loop-mediated
isothermal amplification-based assays (LAMP). RITD is the most common test for
influenza, as it can confirm influenza in just 30 minutes.
Serological
assays are segmented into primary serological tests, secondary serological
tests, and tertiary serological tests. Primary serological tests cover
enzyme-linked immunosorbent assay (ELISA), immunofluorescent antibody technique
(IFAT) and radioimmunoassay (RIA). Secondary Serological tests include
agglutination tests, complement fixation tests (CFT), precipitation tests,
serum neutralization tests (SNT) and toxin-antitoxin test.
Regional Analysis
The
regional segmentation of the global influenza diagnostics
market report is into the Americas (North America & South America),
Europe, Asia Pacific, and Middle East & Africa (MEA). North America is
believed to be the largest market for global influenza diagnostics due to
advanced healthcare facilities and the increasing presence of major market
players in this region. Compared to North America, South America is a
moderately smaller market, but that is not due to lack of demand but due to the
lack of awareness, lack of advanced technology and lesser budgets for healthcare.
In North America, the largest markets are Canada and the United States of
America (USA).
After
North America, Europe is the largest market for influenza diagnostics. Here due
to reasons same as North America, Western Europe stands with the lion's share
in Europe market, compared to Eastern Europe. In Western Europe, the biggest
markets are France, Germany, Italy, Spain and the United Kingdom (UK), followed
by the rest of Europe.
During
the forecast period, Asia Pacific region is expected to experience large-scale
growth of influenza diagnostics market with China, India, Japan, and South
Korea emerging as major markets. Remarkable growth is also expected in the
remaining countries of the Asia Pacific region.
However,
compared to the Asia Pacific, MEA is expected to have limited growth, with
Egypt, Saudi Arabia and the United Arab Emirates (UAE) emerging as the best
bets for influenza diagnostics market investors. The low market in the MEA
region is primarily due to the lack of technology and education.
About US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact us:
Market
Research Future (part of Wantstats Research and Media Private Limited),
99
Hudson Street,5Th Floor, New York,
New
York 10013
United
States of America
